Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Precision Oncology in Lung Cancer Surgery. Local targets link to admitted publications; unresolved targets remain external evidence.
Hugh Morriston Davies and lobectomy for cancer, 1912
10.1016/s0003-4975(10)64672-3 · 1988 · External reference
The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives-State of the Art
10.3390/cancers13153711 · 2021 · External reference
Precision Surgery in NSCLC
10.3390/cancers15051571 · 2023 · External reference
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
10.1056/nejmoa0810699 · 2009 · External reference
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer
10.1056/nejmoa1214886 · 2013 · External reference
Immune checkpoint inhibitors for lung cancer treatment: a review
10.3390/jcm9051362 · 2020 · External reference
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
2015 · External reference
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
10.1200/jco.2007.13.9030 · 2008 · External reference
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
10.1016/s0140-6736(13)62159-5 · 2014 · External reference
Update 2020: Management of Non-Small Cell Lung Cancer
10.1007/s00408-020-00407-5 · 2020 · External reference
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
10.21037/tlcr-22-617 · 2022 · External reference
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021
10.6004/jnccn.2021.0013 · 2021 · External reference
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
10.1056/nejmoa1408440 · 2014 · External reference
Efficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable non-small cell lung cancer by a meta-analysis
10.1016/j.chest.2015.12.017 · 2016 · External reference
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
10.1186/s40425-018-0382-2 · 2018 · External reference
PD-L1 testing in non-small cell lung cancer: past, present, and future
10.4132/jptm.2019.04.24 · 2019 · External reference
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
10.3389/fimmu.2022.823618 · 2022 · External reference
Novel treatment strategies for early-stage lung cancer: the oncologist’s perspective
10.21037/jtd.2020.02.46 · 2020 · External reference
Schiff and the history of open-chest cardiac massage
10.1016/s0300-9572(02)00028-x · 2002 · External reference
Ludwig Rehn: the first successful cardiorrhaphy
10.1016/s0003-4975(10)61972-8 · 1985 · External reference
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study
10.1200/jco.2007.12.6649 · 2007 · External reference
The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies
10.1093/ejcts/ezw239 · 2017 · External reference
Long-term survival of thoracoscopic surgery compared with open surgery for clinical N0 adenocarcinoma
10.21037/jtd-20-2259 · 2020 · External reference
VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis
10.3390/cancers15020414 · 2023 · External reference
Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial
10.1016/s1470-2045(16)00173-x · 2016 · External reference
Compare the prognosis of Da Vinci robot-assisted thoracic surgery (RATS) with video-assisted thoracic surgery (VATS) for non-small cell lung cancer: A Meta-analysis
10.1097/md.0000000000017089 · 2019 · External reference
Adoption of Robotic Core Technology in Minimally Invasive Lung Segmentectomy: Review
10.3390/jpm12091417 · 2022 · External reference
[Robotics in thoracic surgery]
2023 · External reference
A Comparison of Total Thoracoscopic and Robotic Surgery for Lung Cancer Lymphadenectomy
10.3390/cancers15133442 · 2023 · External reference
Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases
10.1016/j.jtcvs.2014.03.019 · 2014 · External reference
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
10.1056/nejmoa2212083 · 2023 · External reference
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
10.1016/s0140-6736(21)02333-3 · 2022 · External reference
Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection
10.1016/j.jtcvs.2018.03.113 · 2018 · External reference
Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections
10.1016/j.athoracsur.2012.04.059 · 2012 · External reference
Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
10.1016/j.athoracsur.2015.05.100 · 2015 · External reference
Evaluation of adherence to the Commission on Cancer lung cancer quality measures
10.1016/j.jtcvs.2018.09.126 · 2019 · External reference
American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection
10.1016/j.athoracsur.2021.05.051 · 2022 · External reference
Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer?
10.1007/s00595-016-1387-4 · 2017 · External reference
Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer
10.1186/s13019-015-0253-6 · 2015 · External reference
Intraoperative molecular imaging: 3rd biennial clinical trials update
10.1117/1.jbo.28.5.050901 · 2023 · External reference
Intraoperative molecular imaging in thoracic oncology: pushing the boundaries of precision resection for occult non-small cell lung cancer in the era of minimally invasive surgery
10.21037/jtd-22-1100 · 2022 · External reference
Optimization of the enhanced permeability and retention effect for near-infrared imaging of solid tumors with indocyanine green
2015 · External reference
Near-Infrared Intraoperative Molecular Imaging Can Locate Metastases to the Lung
10.1016/j.athoracsur.2016.08.079 · 2017 · External reference
A Clinical Trial of TumorGlow to Identify Residual Disease During Pleurectomy and Decortication
10.1016/j.athoracsur.2018.06.015 · 2019 · External reference
Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas
10.1016/j.jtcvs.2018.10.169 · 2019 · External reference
Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial
10.1016/j.jtcvs.2023.02.025 · 2023 · External reference
A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection
10.1158/1078-0432.ccr-22-1215 · 2022 · External reference
Real-time augmented reality for delineation of surgical margins during neurosurgery using autofluorescence lifetime contrast
10.1002/jbio.201900108 · 2020 · External reference
Location-Dependent Spatiotemporal Antialiasing in Photoacoustic Computed Tomography
10.1109/tmi.2022.3225565 · 2023 · External reference